COGNITIVE FINANCE GROUP QU-001
IRB-APPROVED RESEARCH PROTOCOL
Studying financial decisions under pressure.
Can EEG-based neurofeedback influence how people respond to financial risk and simulated losses?
Cognitive Finance Group investigates this question through QU-001, a randomized, sham-controlled pilot study using the Behavioral Market Simulation (BMS).
Eligibility screening is available for Quinnipiac University students age 18 and older. Screening does not guarantee enrollment.
ABOUT THE INITIATIVE
Research at the intersection of neuroscience and finance.
Cognitive Finance Group is a research initiative operated by Cognitive Finance Fund LLC.
QU-001 is its flagship pilot study. The Behavioral Market Simulation (BMS) is the platform used to present simulated market events and record participant decisions.
The initiative investigates behavioral responses in a research setting. It does not manage investments or claim to improve real-world investment performance.
Learn about QU-001 ↗THE RESEARCH ENVIRONMENT
See the Behavioral Market Simulation.
The BMS presents programmed market changes and disruptions in a controlled environment, allowing researchers to observe how participants respond to comparable scenarios.
Explore the BMS platform ↗Research transparency: This recording demonstrates the simulation environment. It does not display or establish QU-001 study findings.
THE STUDY APPROACH
How QU-001 works.
QU-001 compares active EEG-based neurofeedback with sham training to investigate whether participants differ in their responses to simulated market stress.
Neurofeedback
Participants receive assigned active or sham training as specified by the approved study protocol.
Market Simulation
The BMS presents standardized trading scenarios involving controlled volatility, simulated losses, and market disruptions.
Behavioral Response
Researchers examine risk decisions, rule adherence, consistency, and responses following simulated losses.
RESEARCH STATUS
Where QU-001 stands.
The study protocol is approved and eligibility screening is available. The planned sample is 40 participants across active and sham groups. This is a recruitment target, not completed enrollment.
-
✓
COMPLETE
Study Design
Research protocol developed.
-
✓
APPROVED
IRB Ethics Review
Quinnipiac University Protocol #10126.
-
03
SCREENING AVAILABLE
Participant Recruitment
Eligibility questionnaire available.
-
04
PENDING
Results and Analysis
No QU-001 outcomes established.
QU-001 has received Institutional Review Board approval and is preregistered on OSF. Approval reflects ethics review of the study protocol. It does not demonstrate neurofeedback effectiveness or establish the scientific validity of the BMS. Study findings remain pending.
View OSF preregistration ↗PEOPLE BEHIND THE WORK
A multidisciplinary research team.
Contributors bring experience in finance, academic research, clinical neurofeedback, and software development.
Matthew Fehmel
Founder & Principal Investigator
Dr. David A. Tomczyk
Faculty Co-Investigator
Anthony Silver
Clinical Neurofeedback Advisor
Ebiperre Iyoro
Lead Developer, BMS Platform
PARTICIPATE IN RESEARCH
Interested in taking part?
Eligibility screening is available for Quinnipiac University students age 18 and older.
Review the research information and complete the questionnaire to find out whether you may qualify for QU-001.
Screening does not guarantee enrollment. The study team provides participation details and informed consent information.
FOR RESEARCHERS & COLLABORATORS
Explore the research. Start a conversation.
Review the QU-001 study design, meet the contributors, or contact Cognitive Finance Group with questions about research collaboration and the BMS platform.